You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rare Disease

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis 1 Trial in Baltimore, Redwood City

Recruiting
  • Neurofibromatosis 1
    • Baltimore, California
    • +1 more
    Aug 17, 2022

    Dementia Alzheimers Trial in Stavanger (predictive value of a blood test)

    Recruiting
    • Dementia Alzheimers
    • predictive value of a blood test
    • Stavanger, Norway
      Stavanger University Hospital
    May 30, 2022

    A Qualitative Investigation of CLEAT Participants

    Not yet recruiting
    • Osteoarthritis
    • Qualitative Investigation of Participant Experiences
    • (no location specified)
    Jul 6, 2023

    Open Cholecystectomy Among Patients Undergoing Laparoscopic

    Completed
    • Cholelithiasis
    • +2 more
    • No intervention is done
    • Bharatpur, Bagmati, Nepal
      Chitwan Medical College Teaching Hospital
    May 5, 2022

    Parkinson Disease Trial in Philadelphia (IMAGINE-PD, Virtual genetic counseling, Telephone genetic counseling)

    Recruiting
    • Parkinson Disease
    • IMAGINE-PD
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania Parkinsons Disease and Movement Disor
    Jan 26, 2022

    Stage IV Pancreatic Cancer Trial in Ramat Gan (Nivolumab, ipilimumab, Stereotactic body radiation therapy)

    Not yet recruiting
    • Stage IV Pancreatic Cancer
    • Ramat Gan, Israel
      Sheba Medical Centre
    Oct 10, 2021

    Disease Recurrence After Curative Surgery for Stage I Colon

    Recruiting
    • Colon Cancer Stage I
    • Colon Cancer
    • Colonic resection
    • Paris, France
    • +23 more
    Feb 16, 2023

    COVID-19 Convalescent Plasma Treatment Trial in Wroclaw (COVID-19 convalescent plasma treatment)

    Terminated
    • COVID-19 Convalescent Plasma Treatment
    • COVID-19 convalescent plasma treatment
    • Wroclaw, Dolnośląskie, Poland
      Wroclaw Medical University
    Mar 24, 2022

    Urgency Urinary Incontinence Trial in Pittsburgh (Brain functional MRI with simplified urodynamics)

    Recruiting
    • Urgency Urinary Incontinence
    • Brain functional MRI with simplified urodynamics
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    Feb 23, 2022

    Parkinson's Disease Trial in Japan (TVP-1012 1mg)

    Completed
    Has Results
    • Parkinson's Disease
    • TVP-1012 1mg
    • Nagoya, Aichi, Japan
    • +55 more
    Feb 17, 2022

    Parkinson's Disease Trial in Japan (TVP-1012 1mg)

    Completed
    Has Results
    • Parkinson's Disease
    • TVP-1012 1mg
    • Nagoya, Aichi, Japan
    • +23 more
    Feb 16, 2022

    McArdle Disease Trial in Madrid, London (REN001)

    Completed
    • McArdle Disease
    • Madrid, Spain
    • +1 more
    Jan 11, 2022

    Femoropopliteal Artery Occlusion, Atherosclerosis Obliterans, Lesion; Vascular Trial in Shanghai (lesion preparation devices,

    Recruiting
    • Femoropopliteal Artery Occlusion
    • +3 more
    • lesion preparation devices
    • plain old balloon angioplasty
    • Shanghai, Shanghai, China
      Shanghai Pudong Hospital
    Jul 22, 2022

    Coronary Heart Disease Trial in Coventry (Polar Ignite Wearable Activity Monitor)

    Recruiting
    • Coronary Heart Disease
    • Polar Ignite Wearable Activity Monitor
    • Coventry, West Midlands, United Kingdom
      Atrium Health Limited
    Jun 17, 2022

    Atrial Fibrillation, Valvular Heart Disease Trial in Beijing (Gene-directed dosage of warfarin, standard dosage of warfarin)

    Completed
    • Atrial Fibrillation
    • Valvular Heart Disease
    • Gene-directed dosage of warfarin
    • standard dosage of warfarin
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences Fuwai Hospital
    Apr 28, 2022

    Glioblastoma Trial in Oklahoma City (OKN 007, Temozolomide, Photon/Proton IMRT)

    Recruiting
    • Glioblastoma
    • OKN 007
    • +2 more
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center, University of Oklahoma Health Sciences
    Jun 17, 2022

    Breast Cancer Trial in Italy (other, behavioral, drug)

    Active, not recruiting
    • Breast Cancer
    • low Glycemic Index Mediterranean diet
    • +5 more
    • Aviano, Italy
    • +6 more
    May 20, 2022

    Hypertension Trial in Augusta (Candesartan, Placebo)

    Active, not recruiting
    • Hypertension
    • Augusta, Georgia
      Georgia Prevention Institute/ Laboratory of Integrative and Exer
    Jul 18, 2022

    Researcher-Subject Relations Trial in Adana (family-centered nutrition education)

    Completed
    • Researcher-Subject Relations
    • family-centered nutrition education
    • Adana, Turkey
      Çukurova Üniversitesi Balcalı Hastanesi
    Jul 18, 2022

    Sickle Cell Disease Trial in Paris (Famotidine 400 mg/50 mL)

    Recruiting
    • Sickle Cell Disease
    • Famotidine 400 mg/50 mL
    • Paris, France
      Necker - Enfants malades Hospital; Department of Pediatrics and
    Oct 10, 2022

    Lung Tumors, Lung Surgery, Enhanced Recovery After Surgery Trial (Intraoperative air leak test, Intraoperative chest drain

    Recruiting
    • Lung Neoplasms
    • +6 more
    • Intraoperative air leak test
    • +2 more
    • Aarhus, Aarhus N, Denmark
    • +1 more
    Sep 6, 2022

    Platelet Activation Affecting Rate of Vascular Access Patency

    Recruiting
    • Platelet Activation
    • Hemodialysis Fistula Thrombosis
    • platelet activation factors
    • Seoul, Non US/Canada, Korea, Republic of
      Korea university anam hospital
    Dec 8, 2021

    Disease Activity and Adverse Events of Upadacitinib in Adult

    Recruiting
    • Ulcerative Colitis
      • Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina
      • +13 more
      Aug 16, 2022

      Circulating Biomarkers in the Development of Type 1 Diabetes

      Recruiting
      • Diabetes
      • One-time blood (up to 100 ml) will be drawn and the amount of blood drawn is based on weight. Saliva and urine will be collected during the blood draw visit.
      • Duarte, California
        City of Hope Medical Center
      Aug 16, 2022

      NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab (MSB0010718C), Axitinib (AG-013736))

      Active, not recruiting
      • Non-Small Cell Lung Cancer
      • Urothelial Cancer
      • Avelumab (MSB0010718C)
      • Axitinib (AG-013736)
      • Glendale, Arizona
      • +36 more
      Aug 16, 2022